Insights
Thoughts on strategy, innovation, and market growth.
The Science of Beauty: How Testing, Ethics and Market Forces Are Rewriting an Industry
The beauty industry is evolving beyond aesthetics and glamour. At its core, science is shaping everything from formulation to testing, pushing brands to rethink how innovation, ethics, and identity coexist in a world that demands both transparency and trust.
Read more →Tariff Turbulence and Biotech: Navigating the New Trade Crosswinds
Global tariffs are creating ripples beyond consumer goods and manufacturing. In biotechnology, the effects touch clinical trials, investment flows, and collaboration, challenging the sector to stay resilient and…
Read more →From Funding Freeze to Focus: How Biotech Is Rewriting Its Growth Story
After years of abundant capital, biotech faces a harder, leaner funding climate. But the correction may be a blessing in disguise, forcing sharper focus on execution, partnerships, and value creation. What emerges next could…
Read more →The Quiet Disruption: AI's Uneven March into Biotech
AI is reshaping biotechnology in subtle but uneven ways. While discovery accelerates, clinical development and regulation remain stubbornly complex. The result is not a revolution, but a quiet, incremental shift that may redefine how biotech grows and collaborates in the years ahead…
Read more →